Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
16,042,165
-
Shares change
-
+3,018,809
-
Total reported value, excl. options
-
$393,156,090
-
Value change
-
+$85,113,129
-
Put/Call ratio
-
133%
-
Number of buys
-
70
-
Number of sells
-
-23
-
Price
-
$24.51
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2020
108 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q2 2020.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,042,165 shares
of 43,411,663 outstanding shares and own 37% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (2,325,388 shares), BlackRock Inc. (1,931,756 shares), Avoro Capital Advisors LLC (1,870,000 shares), VANGUARD GROUP INC (1,337,660 shares), STATE STREET CORP (1,026,881 shares), Slate Path Capital LP (870,694 shares), Corriente Advisors, LLC (659,987 shares), Woodline Partners LP (659,395 shares), GEODE CAPITAL MANAGEMENT, LLC (377,238 shares), and NORTHERN TRUST CORP (351,218 shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.